XTL Biopharmaceuticals Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NOKED ISRAEL LTD | 11/13/2025 | 198.89 K | $233.00 K | 0.00% | 2.96% |
| RHUMBLINE ADVISERS | 11/06/2025 | 17.26 K | $20.19 K | 0.00% | 0.26% |
| MORGAN STANLEY | 11/14/2025 | 10.01 K | $11.71 K | -9.08% | 0.15% |
| UBS GROUP AG | 11/13/2025 | 763 | $893 | -42.89% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
XTL Biopharmaceuticals Ltd. institutional Ownership - FAQ's
During the previous two years, 5 institutional investors and hedge funds held shares of XTL Biopharmaceuticals Ltd.. The most heavily invested institutionals were:
Noked Israel Ltd: 198,888
RHUMBLINE ADVISERS: 17,261
MORGAN STANLEY: 10,011
UBS Group AG: 763
Noked Capital LTD: 198,888
3.37% of XTL Biopharmaceuticals Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 425.81 K shares in the last 24 months. This purchase volume represents approximately $502.46 K in transactions.